AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

It has been a wild summer for artificial-intelligence stocks. Beijing’s flaunting of China’s AI progress, among other factors, sent American stocks sliding last week. The week before saw a selloff of ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Troy Segal is an editor and writer. She has 20+ years of experience covering personal finance, wealth management, and business news. Gordon Scott has been an active investor and technical analyst for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals Inc insiders reported 3 transactions totaling $430,930.56. Activity included 2 tax payments ($333,430.56) and 1 sale ($97,500.00) in August 2026. View more Major Holders ...